Skip to main content
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • General Statistics
    • Editorial Board
    • Editors
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Acknowledgment of Reviewers
    • Clinical Implications
    • Clinical-Pathological Conferences
    • Controversies in Hypertension
    • Editors' Picks
    • Guidelines Debate
    • Meeting Abstracts
    • Recent Advances in Hypertension
    • SPRINT Trial: the Conversation Continues
  • Resources
    • Instructions to Reviewers
    • Instructions for Authors
    • →Article Types
    • → Submission Guidelines
      • Research Guidelines
        • Minimum Information About Microarray Data Experiments (MIAME)
      • Abstract
      • Acknowledgments
      • Clinical Implications (Only by invitation)
      • Conflict(s) of Interest/Disclosure(s) Statement
      • Figure Legends
      • Figures
      • Novelty and Significance: 1) What Is New, 2) What Is Relevant?
      • References
      • Sources of Funding
      • Tables
      • Text
      • Title Page
      • Online/Data Supplement
    • →Tips for Easier Manuscript Submission
    • → General Instructions for Revised Manuscripts
      • Change of Authorship Form
    • → Costs to Authors
    • → Open Access, Repositories, & Author Rights Q&A
    • Permissions to Reprint Figures and Tables
    • Journal Policies
    • Scientific Councils
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Facebook
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Hypertension

  • My alerts
  • Sign In
  • Join

  • Facebook
  • Twitter
  • Home
  • About this Journal
    • General Statistics
    • Editorial Board
    • Editors
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Acknowledgment of Reviewers
    • Clinical Implications
    • Clinical-Pathological Conferences
    • Controversies in Hypertension
    • Editors' Picks
    • Guidelines Debate
    • Meeting Abstracts
    • Recent Advances in Hypertension
    • SPRINT Trial: the Conversation Continues
  • Resources
    • Instructions to Reviewers
    • Instructions for Authors
    • →Article Types
    • → Submission Guidelines
    • →Tips for Easier Manuscript Submission
    • → General Instructions for Revised Manuscripts
    • → Costs to Authors
    • → Open Access, Repositories, & Author Rights Q&A
    • Permissions to Reprint Figures and Tables
    • Journal Policies
    • Scientific Councils
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
Scientific Contributions

Heritability of Central Systolic Pressure Augmentation

A Twin Study

Harold Snieder, Christopher S. Hayward, Ursula Perks, Raymond P. Kelly, Paul J. Kelly, Tim D. Spector
Download PDF
https://doi.org/10.1161/01.HYP.35.2.574
Hypertension. 2000;35:574-579
Originally published February 1, 2000
Harold Snieder
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher S. Hayward
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ursula Perks
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raymond P. Kelly
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul J. Kelly
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tim D. Spector
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Info & Metrics
  • eLetters

Jump to

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics
  • eLetters
Loading

Abstract

Abstract—Less than 50% of the variance in left ventricular mass is explained by conventional factors such as age, blood pressure, and body size. Genetic influences may account for part of the unexplained variance. The central (aortic) pressure augmentation index has been suggested as a noninvasive measure of pulsatile load, which is a likely determinant of left ventricular mass. We quantified the genetic influence on augmentation index and determined the extent to which this influence is dependent on the effects of age, height, heart rate, and blood pressure. We performed a classical twin study composed of 225 monozygotic and 594 dizygotic female white twin pairs aged 18 to 73 years. Augmentation index and mean arterial pressure were based on the central pressure wave derived from the radial waveform as measured by applanation tonometry. Quantitative genetic modeling techniques were used to analyze the data. The heritability of augmentation index was 37%, whereas heritabilities for blood pressure traits varied between 13% and 25%. Most of the variance in augmentation index could be explained by genetic and environmental factors specifically influencing augmentation index. Only a relatively small part of the total variance in augmentation index could be attributed to genes in common with height (3.1%), heart rate (4.6%), and mean arterial pressure (5.6%). Age explained 19% of the total variation in augmentation index. In conclusion, augmentation index has a significant heritable component, which is largely independent of the influence of blood pressure, heart rate, height, and age. Finding genes for the augmentation index could help to unravel pathophysiological mechanisms causing left ventricular hypertrophy and lead to improvements in prevention, diagnosis, and treatment of at-risk populations.

  • genetics
  • twins
  • augmentation index
  • blood pressure
  • aging
  • hypertrophy

Despite large, prospective, epidemiological studies examining determinants of left ventricular mass,1 2 3 4 <50% of the variance in left ventricular mass is explained by conventional factors such as age, blood pressure (BP), and body size.4 It has been suggested that inheritance may account for part of the unexplained variance.5 6 7 One hemodynamic factor that has been suggested to influence left ventricular mass is pulsatile vascular load,8 9 10 although this has been difficult to measure in large populations. Murgo et al11 showed that patterns of augmentation index (AI) relate to invasively measured pulsatile vascular load. Recent studies indicate that the AI can be measured accurately noninvasively, providing a reliable method of studying arterial properties in a large population.12

AI is defined as the ratio of augmented systolic pressure (due to the late systolic peak in the central pressure waveform) to pulse pressure8 and represents a measure of a combination of factors related to large arterial function. It is increased in association with arterial stiffness, caused by the degeneration of the arterial wall as a result of repetitive cyclic stress, which is a major determinant of increasing systolic pressure with age and in patients with hypertension.13 Stiffening of the main central arteries also leads to increased velocity of the pulse wave as it travels down the arteries, which causes wave reflections from peripheral sites to return earlier, increasing the dominance of the late systolic peak in the aortic pressure wave. This elevated central systolic pressure increases left ventricular load and myocardial oxygen demand, serves as a stimulus to hypertrophy, and hinders left ventricular ejection, predisposing to left ventricular failure.14 A second major influence on the AI is the intensity of wave reflection. This may explain the more prominent secondary (augmented) pressure peak in shorter subjects and in women compared with men.15 By increasing arterial stiffness, age also increases the intensity of wave reflection as a result of a decrease in the attenuation of reflected waves by the relatively stiffer arterial tree. The importance of AI is supported by studies that show this measure to be an independent determinant of left ventricular mass,9 16 which is considered a stronger predictor of cardiovascular events than BP.17

To date very little is known about the importance of genetic factors in the development of large arterial function. While both systolic (SBP) and diastolic BP (DBP) have been shown to be heritable to a variable extent,18 19 20 21 22 there is no similar information on arterial function itself. Applanation tonometry provides a means whereby information on arterial function, quantified by the AI, can be widely and accurately collected. A feature of AI, however, is its strong dependence on age,8 23 height,15 16 24 heart rate,15 25 and BP.15 26 It is therefore possible that any genetic influence on AI is, at least partly, due to genes in common with mean arterial pressure (MAP), heart rate, and height.

The aim of this study, therefore, was to quantify the genetic and environmental sources of individual differences in AI and to determine the extent to which they are mediated by or dependent on the effects of age, height, heart rate, and MAP. A classical twin design was used to answer these questions. AI and MAP were based on the central aortic pressure wave derived from the radial waveform as measured by applanation tonometry8 27 in a large sample of unselected female twins across a broad age range. Both univariate and multivariate quantitative genetic modeling techniques were used to analyze the data.

Methods

Subjects

The study cohort was composed of 819 female white twin pairs (225 monozygotic [MZ] and 594 dizygotic [DZ]) aged 18 to 73 years from the St Thomas’ UK Adult Twin Registry.28 Twins from the registry were ascertained from the general population through national media campaigns in the United Kingdom.29 Participating twins were unaware of the specific hypotheses tested, and informed consent was obtained from all subjects. The study was approved by the St Thomas’ Hospital Research Ethics Committee. Zygosity was determined by standardized questionnaire, and DNA fingerprinting was used for confirmation.29 Information on medical history, medication use, lifestyle, and demographic variables was obtained by standardized nurse-administered questionnaire.

Measures

Subjects were interviewed and studied by trained research nurses. Height was measured to the nearest 0.5 cm with the use of a wall-mounted stadiometer. Weight (light clothing only) was measured to the nearest 0.1 kg with digital scales. Brachial BP was measured with an automated cuff sphygmomanometer (OMRON HEM713C) with the subject in the seated position under standardized conditions. The average of 2 BP readings was recorded.

The radial arterial pressure waveform was recorded with the subject supine with the use of applanation tonometry30 and commercially available acquisition and analysis software (SphygmoCor, PWV Medical). Applanation tonometry records fluctuations in the pressure wave by a high-fidelity transducer incorporated into the tip of a pencil-shaped probe. Radial artery recordings were taken because this artery is ideal for tonometry since the artery is supported by the bone of the radius behind, allowing accurate applanation (flattening) by the probe. From this recording, the central arterial pressure was derived with the use of a generalized transfer function, which has previously been shown to (1) give an accurate estimate of the central arterial pressure waveform and its characteristics,31 (2) be constant across individuals, and (3) be constant across conditions as diverse as exercise-related systolic hypertension and the hypotension associated with cardiac failure.32 33

The radial pressure waveform was calibrated to the measured brachial sphygmomanometric pressure, and MAP was derived by integration. The central DBP and MAP were set as equal to the brachial DBP and MAP in the generalized transfer function since it has been shown that these change little in transit down the circulation.34 35

The AI was based on the central aortic pressure wave derived from the radial waveform, as discussed above. As outlined previously, the central pressure waveform is characterized by an early and a late systolic peak in the majority of individuals. The AI is defined as the difference between the early and late pressure peaks divided by the pulse pressure (Figure 1⇓).8 11 In our study, intraobserver and interobserver reproducibility for AI, expressed as mean intraclass correlations, were 0.82 and 0.84, respectively.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Graphic representation of AI, defined as the ratio of augmented systolic pressure (ΔP) to pulse pressure (PP).

Analytical Approach

The aims of our analyses were 2-fold. First, to estimate the influence of genetic factors on AI and a range of BP-related variables, we applied univariate model-fitting techniques. Second, to determine the extent to which the genetic influence on AI is dependent on age, height, heart rate, and MAP, we used multivariate modeling.

Univariate Twin Analysis

Details of univariate model fitting to twin data have been described elsewhere.36 37 38 In short, the technique is based on the comparison of the variance-covariance matrices in MZ and DZ twin pairs and allows separation of the observed phenotypic variance into additive (A) or dominant (D) genetic components and shared (C) or unique (E) environmental components. The latter also contains measurement error. Dividing each of these components by the total variance yields the different standardized components of variance, for example, heritability (h2), which can be defined as the ratio of additive genetic variance to total phenotypic variance. By incorporating age into the model, the influence of age on the phenotype can also be quantified.39 Extension of this univariate (1 variable) model to a model including multiple variables (multivariate) additionally allows exploration of whether the origin of the covariance between height, heart rate, MAP, and AI is genetically and/or environmentally determined.

Multivariate Twin Analysis

A triangular or Cholesky decomposition36 40 including height, heart rate, MAP, AI, and age was used in the multivariate model fitting. This model enabled us to quantify which part of the (genetic or environmental) variance components was specific to AI and which part was due to the influence of height, heart rate, MAP, or age.

Figure 2⇓ shows the triangular decomposition of the genetic and environmental factors for the 4 phenotypes (and age) included in the analysis. The number of latent factors equals the number of variables. Only 1 twin of a pair is shown. The first factor contributes to all 4 variables, the second factor influences the subsequent 3 variables, and so on. The last factor only influences AI. The observed phenotypes are shown in squares, and latent factors are shown in circles. Factor loadings of observed variables on the different latent factors are represented by the arrows. Factor loadings for the last factor (A4, C4, E4) reflect influences specific to AI and can be represented by hAI, cAI, and eAI respectively. The heritability of AI corrected for the influence of height, MAP, and age can be calculated as follows: h2cor=h2AI/(h2AI+c2AI+e2AI).

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Path diagram showing the influence of age, genetic (A), and environmental (C and E) factors on height, heart rate, MAP, and AI (Cholesky decomposition). The observed phenotypes are shown in squares, and latent factors are shown in circles. Factor loadings of observed variables on the different latent factors are represented by the arrows. For clarity, only 1 twin of a pair is shown, and arrows loading on the latent factors A and C are omitted. HR indicates heart rate.

The genetic correlation (rg) between 2 traits gives an indication of the amount of overlap between (sets of) genes influencing those traits. rg is calculated as the (additive) genetic covariance (COVA) between 2 traits divided by the square root of the product of the total genetic variance components of each of the traits. The genetic correlation between, for example, MAP and AI therefore equals rg=COVA(MAP, AI)/√ (VAMAP*VAAI).

Shared and unique environmental correlations are calculated in a similar fashion.

Model Fitting

A series of submodels nested within the full-parameter Cholesky model were fitted to the multivariate variance-covariance matrices. The significance of variance components A, C, D, and age was assessed by testing the deterioration in model fit after each component was dropped from the full model, leading to a model in which the pattern of variances and covariances is explained by as few parameters as possible. Submodels were compared with the full model by hierarchical χ2 tests. The difference in χ2 values between submodel and full model is itself approximately distributed as χ2, with degrees of freedom (df) equal to the difference in df of submodel and full model. Model selection was also guided by Akaike’s information criterion (AIC=χ2−2df). The model with the lowest AIC reflects the best balance between goodness of fit and parsimony.

Statistical Software

Data handling and preliminary analyses were done with STATA.41 Univariate and multivariate quantitative genetic modeling were performed with Mx.42

Results

General Characteristics

Fifty twin pairs (12 MZ and 38 DZ) were excluded from the final analysis. In at least 1 twin of 47 pairs (51 individuals or 3.1% of the cohort), an arterial waveform could either not be obtained or the measurement was of insufficient quality. Three pairs were excluded, of which 1 twin had an extremely low, and presumed erroneous, AI (<4 SD below the mean). Thus, the total number of twin pairs included in the final analysis was 213 MZ and 556 DZ pairs (1538 subjects).

General characteristics of the twins who were included in the final analyses are shown in Table 1⇓. Characteristics were very similar in the 2 zygosity groups. Results after exclusion of all pairs of which at least 1 twin was on either antihypertensive or hypoglycemic medication (Table 1⇓) were virtually identical to those of the entire group. The results presented here are therefore based on the entire group.

View this table:
  • View inline
  • View popup
Table 1.

Characteristics of MZ and DZ Twin Pairs of the Study Sample

Univariate Analysis

For all measures, intraclass correlations in MZ twin pairs were larger than those in DZ twin pairs, indicating substantial genetic influences on all traits (Table 2⇓). This pattern was confirmed by the univariate model fitting. Parameter estimates of the best fitting univariate models and their 95% CI are shown in Table 3⇓. The heritability of AI was estimated at 37%, whereas age explained 19% of the variance. In the best model for AI, C could be dropped without a deterioration in fit (χ2[1]=0.0; P=1.0), ie, the contribution of shared environment to AI was not significant.

View this table:
  • View inline
  • View popup
Table 2.

Intraclass Correlations for MZ and DZ Twin Pairs

View this table:
  • View inline
  • View popup
Table 3.

Parameter Estimates and 95% CIs of the Best-Fitting Univariate Models (Based on AIC)

For all BP variables (including heart rate), a full ACE model was chosen as the best model, on the basis of the lowest AIC. Although this method of model selection led to a consistent picture for all BP traits with ACE models providing the most realistic explanation of the data, for several BP traits, h2, c2, or both were not always strictly significant, ie, the CI included zero (see Table 3⇑). Heritabilities ranged from 13% to 25% in the BP variables, whereas shared environment and age explained 12% to 18% and 8% to 20% of the variance, respectively. No influence of age on heart rate was found. Height showed the expected large genetic component (60%) and a somewhat smaller influence of shared environment (25%).

Multivariate Analysis

Values of phenotypic correlations (n=1538) were as expected: AI was positively correlated with age (r=0.44) and MAP (r=0.33) and negatively with heart rate (r=−0.28). Taller women had a lower AI (r=−0.21), most likely due to later wave reflection from more distant peripheral reflecting sites.15 16 24

Results of the multivariate model fitting, including height, heart rate, MAP, AI, and age, are shown in Table 4⇓. Both hierarchical χ2 tests and AIC values indicated that the ACE model including age showed the best fit to the data. Neither C nor A could be dropped from the full ACE model because both the AE (χ2[10]=37.0; P<0.001) and the CE model (χ2[10]=123.2; P<0.001) showed a significant deterioration in fit. There was no indication of a dominant genetic influence because the ACE model showed a better fit to the data than the ADE model. The influence of age could not be dropped from the ACE model without a significant reduction in fit (χ2[4]=318.2; P<0.001).

View this table:
  • View inline
  • View popup
Table 4.

Results of Multivariate Model Fitting

Parameter estimates of the best-fitting multivariate model are not shown because they were virtually identical to the univariate parameter estimates. Moderate genetic correlations between AI and MAP (rg=0.38), AI, and heart rate (rg=−0.38) and between AI and height (rg=−0.29) were found. Unique environmental correlations for the same pairs of variables were smaller, with values of 0.15, −0.32, and −0.02. These results indicate that the phenotypic correlations between especially AI and MAP and AI and height are predominantly due to shared genes influencing these traits.

Sources of variance in AI are shown in Table 5⇓. The last column lists the amount of variance in AI explained by age, height, heart rate, MAP, and AI specific factors. Each of these sources of variance is additionally decomposed in genetic, shared, and unique environmental factors. In the best-fitting multivariate model, 36.5% of the variance in AI was determined by genetic factors, of which 5.6% was due to genes in common with MAP, 4.6% to genes in common with heart rate, and 3.1% to genes in common with height. Approximately 44% was due to unique environmental variation, of which 2.6% was due to environmental influences in common with MAP and 4.6% in common with heart rate. The contribution of shared environment to AI was negligible. It is clear from Table 5⇓ that most of the total phenotypic variance in AI (60.2%) is explained by genetic and unique environmental factors specific to AI, with height (3.1%), heart rate (9.5%), and MAP (8.4%) contributing only relatively small parts of the variance. The remaining variation in AI (18.8%) could be attributed to the effect of age. The heritability of AI adjusted for age, height, heart rate, and MAP equalled the following: h2cor=0.232/(0.232+0.0+0.37)=0.38.

View this table:
  • View inline
  • View popup
Table 5.

Sources of Variance in AI Based on Best-Fitting Multivariate Model

Discussion

This study quantified genetic and environmental sources of variance in AI and investigated to what extent these were dependent on the effects of age, height, heart rate, and BP. Furthermore, it was estimated how much of the variation in central and peripheral SBP, MAP, DBP, pulse pressure, and heart rate was due to genetic factors. To our knowledge, our study is the first to report heritabilities of AI, central SBP, and pulse pressure and is the largest twin study that measured SBP and DBP.18 43 44 AI was used as the primary end point in our study because it is an index of pulsatile load and may help to elucidate the genetic basis of hemodynamic mechanisms contributing to hypertrophy of the left ventricle. Total heritability of AI was higher (37%) than the heritabilities for the BP traits, which varied between 13% and 25%. Most of the variance in AI could be explained by genetic and environmental factors specifically influencing AI. Although AI had some genes in common with heart rate, MAP, and height, as evident from the genetic correlations, only a relatively small part of the total variance in AI could be attributed to these genes: 3.1%, 4.6%, and 5.6% for height, heart rate, and MAP, respectively. A considerable portion of the total variation in AI could be explained by age (18.8%), confirming the importance of the effect of aging on systolic augmentation.8 15 23 The heritability of AI adjusted for age, height, heart rate, and MAP (38%) was highly similar to the unadjusted heritability (37%). The absence of a common environmental effect on AI indicates that influences due to a shared family environment in childhood (eg, dietary influences) have little bearing on AI in later life.

The heritability estimates for central SBP and pulse pressure were both relatively small but similar to the estimate for peripheral SBP. Interestingly, age had a larger effect on central than on peripheral SBP, which may reflect the larger effect of aging on systolic augmentation.23 It may also be related to the greater amplification of the pulse between central and peripheral arteries in the more compliant arterial system of youth. As the arteries stiffen with age, amplification decreases, and central pressure more closely approximates peripheral pressure.45

Intraclass correlations for the BP-related variables were as high as one would expect for traits showing a considerable amount of intraindividual variation. Intraclass correlations for peripheral SBP and DBP were very similar to those reported in earlier studies, although heritability estimates in our study were somewhat lower.18 19 20 21 22 43 44 One reason for this difference may be that twin studies have little power to discriminate between additive genes or shared environment as sources of familial resemblance unless a multivariate approach is used.22 46 Earlier twin studies on BP were substantially smaller than our study and therefore lacked the power to detect a shared environmental component, which may have led to inflated estimates of heritability. Even with a twin study of our size, we had difficulty in making the distinction between additive genes and shared environment in univariate analyses of the BP traits. Another reason for the lower heritability estimates in our study may be the incorporation of age as a variance component in the model. We decided to incorporate age because, if unaccounted for, it can spuriously introduce a common environmental effect.39 We would have observed higher heritabilities if we had either ignored the effect of age or had performed the model-fitting analysis using age-adjusted BP values.

Several potential sources of bias may have had an influence on our results. Medication use is unlikely to have had an effect on the model-fitting results since these remained unchanged after exclusion of twins using antihypertensive and hypoglycemic medication. The mean values of general characteristics of MZ and DZ twins in this study were very similar. Only weight and the percentage of postmenopausal twins showed some slight differences between zygosities. Neither weight nor menopausal status was significantly associated with AI in a multiple regression after the inclusion of age (data not shown). Therefore, these minor differences between MZ and DZ twins are unlikely to have biased the results for AI.

The reported results are likely to be representative of the general population because basic characteristics of the twins were similar to a population-based sample of women participating in the Chingford cohort study in London.47 Furthermore, mortality of adult twins has been shown to be similar to that of the general population.48 However, since they were limited to women, the results of our study cannot be generalized to men. Hayward and Kelly15 observed that from an early age, AI was higher in women than in men. This is most likely related to more prominent wave reflection due to shorter stature in women, rather than due to gender differences in arterial stiffness, since women have been shown to have a more compliant arterial tree, at least until the menopause.49 Future twin studies aimed at systematically investigating gender differences in genetic influences on AI should include opposite-sex twin pairs in addition to same-sex male twins.50

Our estimate of heritability for AI provides a yardstick against which the contribution to AI of either candidate genes or novel loci can be evaluated. Since AI is thought to be a composite of arterial stiffness (determined by the structural components of the arterial wall) and wave reflection from peripheral sites, any gene influencing these pathways may be considered a candidate for AI. A fruitful strategy to detect novel loci may be to measure, in addition to AI, 1 or more related traits, for example, pulse wave velocity in a large number of unselected sib pairs or DZ twins for use in a genome screen. AI and pulse wave velocity may be influenced by a common set of genes, which would offer prospects for gene finding since it has been shown that multivariate genetic modeling increases the power to locate pleiotropic quantitative trait loci.51

In summary, AI has a significant genetic component, which is largely independent of the influence of BP, heart rate, height, and age. Finding genes for AI could help to unravel pathophysiological mechanisms causing left ventricular hypertrophy and may lead to improvements in prevention, diagnosis, and treatment of at-risk populations.

Acknowledgments

This study was supported by grants from the British Heart Foundation (Dr Snieder), the National Heart Foundation of Australia (Dr Hayward), and by grants from the Arthritis and Rheumatism Council, Wellcome Trust, Medical Research Council, Chronic Disease Research Foundation, and Gemini Holdings plc. We would like to thank Alex MacGregor for helpful comments and suggestions. We thank the research nurses for skillful data collection and especially all our twin volunteers for their support.

Footnotes

  • Reprint requests to Dr Harold Snieder, Twin Research and Genetic Epidemiology Unit, St Thomas’ Hospital, Lambeth Palace Rd, London SE1 7EH, UK.

  • Received May 24, 1999.
  • Revision received June 15, 1999.
  • Accepted September 15, 1999.

References

  1. ↵
    Levy D, Anderson KM, Savage DD, Kannel WB, Christiansen JC, Castelli WP. Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors: the Framingham Heart Study. Ann Intern Med. 1988;108:7–13.
  2. ↵
    Dannenberg AL, Levy D, Garrison RJ. Impact of age on echocardiographic left ventricular mass in a healthy population (the Framingham Study). Am J Cardiol. 1989;64:1066–1068.
    OpenUrlCrossRefPubMed
  3. ↵
    Lauer MS, Anderson KM, Kannel WB, Levy D. The impact of obesity on left ventricular mass and geometry: the Framingham Heart Study. JAMA. 1991;266:231–236.
    OpenUrlCrossRefPubMed
  4. ↵
    Devereux RB, Roman MJ, de Simone G, O’Grady MJ, Paranicas M, Yeh J, Fabsitz RR, Howard BV. Relations of left ventricular mass to demographic and hemodynamic variables in American Indians: the Strong Heart Study. Circulation. 1997;96:1416–1423.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    Roman MJ, Saba PS, Pini R, Spitzer M, Pickering TG, Rosen S, Alderman MH, Devereux RB. Parallel cardiac and vascular adaptation in hypertension. Circulation. 1992;86:1909–1918.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    Post WS, Larson MG, Myers RH, Galderisi M, Levy D. Heritability of left ventricular mass: the Framingham Heart Study. Hypertension. 1997;30:1025–1028.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    Innes BA, McLaughlin MG, Kapuscinski MK, Jacob HJ, Harrap SB. Independent genetic susceptibility to cardiac hypertrophy in inherited hypertension. Hypertension. 1998;31:741–746.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    Kelly RP, Hayward CS, Avolio AP, O’Rourke M. Noninvasive determination of age-related changes in the human arterial pulse. Circulation. 1989;80:1652–1659.
    OpenUrlAbstract/FREE Full Text
  9. ↵
    Saba PS, Roman MJ, Pinni R, Spitzer M, Ganau A, Devereux RB. Relation of arterial pressure waveform to left ventricular and carotid anatomy in normotensive subjects. J Am Coll Cardiol. 1993;22:1873–1880.
    OpenUrlPubMed
  10. ↵
    Saba PS, Roman MJ, Ganau A, Pini R, Jones EC, Pickering TG, Devereux RB. Relationship of effective arterial elastance to demographic and arterial characteristics in normotensive and hypertensive adults. J Hypertens. 1995;13:971–977.
    OpenUrlPubMed
  11. ↵
    Murgo JP, Westerhof N, Giolma JP, Altobelli S. Aortic impedance in normal man: relationship to pressure waveforms. Circulation. 1980;62:105–116.
    OpenUrlFREE Full Text
  12. ↵
    Chen C-H, Ting C-T, Nussbacher A, Nevo E, Kass DA, Pak P, Wang S-P, Chang M-S, Yin FCP. Validation of carotid artery tonometry as a means of estimating augmentation index of ascending aortic pressure. Hypertension. 1996;27:168–175.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    O’Rourke M. Arterial stiffness, systolic blood pressure, and logical treatment of arterial hypertension. Hypertension. 1990;15:339–347.
    OpenUrlAbstract/FREE Full Text
  14. ↵
    O’Rourke M. Arterial stiffening and vascular/ventricular interaction. J Hum Hypertens. 1994;8(suppl 1):S9–S15.
  15. ↵
    Hayward CS, Kelly RP. Gender-related differences in the central arterial pressure waveform. J Am Coll Cardiol. 1997;30:1863–1873.
    OpenUrlCrossRefPubMed
  16. ↵
    Marchais SJ, Guerin AP, Pannier B, Levy BI, Safar ME, London GM. Wave reflection and cardiac hypertrophy in chronic uremia: influence of body size. Hypertension. 1993;22:876–883.
    OpenUrlAbstract/FREE Full Text
  17. ↵
    Devereux RB, Roman MJ. Inter-relationships between hypertension, left ventricular hypertrophy and coronary heart disease. J Hypertens. 1993;11(suppl 4):S3–S9.
  18. ↵
    Snieder H, Boomsma DI, van Doornen LJP. Genetic developmental trends in blood pressure levels, and blood pressure reactivity to stress. In: Turner JR, Cardon LR, Hewitt JK, eds. Behavior Genetic Approaches in Behavioral Medicine. New York, NY: Plenum; 1995:105–130.
  19. ↵
    Hong Y, de Faire U, Heller DA, McClearn GE, Pedersen N. Genetic and environmental influences on blood pressure in elderly twins. Hypertension. 1994;24:663–670.
    OpenUrlAbstract/FREE Full Text
  20. ↵
    Somes GW, Harshfield GA, Alpert BS, Goble MM, Schieken RM. Genetic influences on ambulatory blood pressure patterns: the Medical College of Virginia Twin Study. Am J Hypertens. 1995;8:474–478.
    OpenUrlCrossRefPubMed
  21. ↵
    Fagard R, Brguljan J, Staessen J, Thijs L, Derom C, Thomis M, Vlietinck R. Heritability of conventional and ambulatory blood pressures: a study in twins. Hypertension. 1995;26:919–924.
    OpenUrlAbstract/FREE Full Text
  22. ↵
    Boomsma DI, Snieder H, de Geus EJC, van Doornen LJP. Heritability of blood pressure increases during mental stress. Twin Res.. 1998;1:15–24.
    OpenUrlCrossRefPubMed
  23. ↵
    Vaitkevicius PV, Fleg JL, Engel JH, O’Connor FC, Wright JG, Lakatta LE, Yin FCP, Lakatta EG. Effects of age and aerobic capacity on arterial stiffness in healthy adults: inter-relationships between hypertension, left ventricular hypertrophy, and coronary heart disease. Circulation. 1993;88:1456–1462.
    OpenUrlAbstract/FREE Full Text
  24. ↵
    London GM, Guerin AP, Pannier BM, Marchais SJ, Metivier F. Body height as a determinant of carotid pulse contour in humans. J Hypertens. 1992;10(suppl 6):S93–S95.
  25. ↵
    Cameron JD, McGrath BP, Dart AM. Use of radial artery applanation tonometry and a generalized transfer function to determine aortic pressure augmentation in subjects with treated hypertension. J Am Coll Cardiol. 1998;32:1214–1220.
    OpenUrlCrossRefPubMed
  26. ↵
    Hayward CS, Knight DC, Wren BG, Kelly RP. Effect of hormone replacement therapy on non-invasive cardiovascular haemodynamics. J Hypertens. 1997;15:987–993.
    OpenUrlCrossRefPubMed
  27. ↵
    O’Rourke MF, Kelly RP, Avolio AP. The Arterial Pulse. Philadelphia, Pa: Lea & Febiger; 1992.
  28. ↵
    Boomsma DI. Twin registers in Europe: an overview. Twin Res. 1998;1:34–51.
    OpenUrlCrossRefPubMed
  29. ↵
    Spector TD, Cicuttini F, Baker J, Loughlin J, Hart D. Genetic influences on osteoarthritis in women: a twin study. BMJ. 1996;312:940–944.
    OpenUrlAbstract/FREE Full Text
  30. ↵
    Kelly RP, Hayward C, Ganis J, Daley J, Avolio A, O’Rourke M. Noninvasive registration of the arterial pressure pulse waveform using high-fidelity applanation tonometry. J Vasc Med Biol. 1989;1:142–149.
    OpenUrl
  31. ↵
    Chen C-H, Nevo E, Fetics B, Pak PH, Yin FCP, Maughan WL, Kass DA. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure: validation of generalized transfer function. Circulation. 1997;95:1827–1836.
    OpenUrlAbstract/FREE Full Text
  32. ↵
    O’Rourke M. Sphygmocardiography. In: Nichols WW, O’Rourke MF, eds. McDonald’s Blood Flow in Arteries. 4th ed. London, UK: Edward Arnold; 1998.
  33. ↵
    Karamonoglu M, O’Rourke MF, Avolio AP, Kelly RP. An analysis of the relationship between central aortic and peripheral upper limb pressure waves in man. Eur Heart J. 1993;14:160–167.
    OpenUrlAbstract/FREE Full Text
  34. ↵
    Pauca AL, Wallenhaupt SL, Kon ND, Ticker WY. Does radial artery pressure accurately reflect aortic pressure? Chest. 1992;102:1193–1198.
    OpenUrlCrossRefPubMed
  35. ↵
    Schwid HA, Taylor LA, Smith NT. Computer model analysis of the radial artery pressure wave. J Clin Monitor. 1987;3:220–228.
    OpenUrlPubMed
  36. ↵
    Neale MC, Cardon LR. Methodology for Genetic Studies of Twins and Families. Dordrecht, Netherlands: Kluwer Academic Publishers; 1992.
  37. ↵
    Snieder H, Boomsma DI, van Doornen LJP, de Geus EJC. Heritability of respiratory sinus arrhythmia: dependency on task and respiration rate. Psychophysiology. 1997;34:317–328.
    OpenUrlPubMed
  38. ↵
    Snieder H, MacGregor AJ, Spector TD. Genes determine the cessation of a woman’s reproductive life: a twin study of hysterectomy and age at menopause. J Clin Endocrinol Metab. 1998;83:1875–1880.
    OpenUrlCrossRefPubMed
  39. ↵
    Neale MC, Martin NG. The effects of age, sex and genotype on self report drunkenness following a challenge dose of alcohol. Behav Genet. 1989;19:63–78.
    OpenUrlCrossRefPubMed
  40. ↵
    Loehlin J. The Cholesky approach: a cautionary note. Behav Genet. 1996;26:65–69.
  41. ↵
    StataCorp. Stata Statistical Software: Release 5.0. College Station, Tex: StataCorp; 1997.
  42. ↵
    Neale MC. Mx: Statistical Modeling. 2nd ed. Richmond, Va: Medical College of Virginia; 1997.
  43. ↵
    Feinleib M, Garrison RJ, Fabsitz R, Christian JC, Hrubec Z, Borhani NO, Kannel WB, Rosenman RH, Schwartz JT, Wagner JO. The NHLBI twin study of cardiovascular disease risk factors: methodology and summary of results. Am J Epidemiol. 1977;106:284–295.
    OpenUrlAbstract/FREE Full Text
  44. ↵
    Austin MA, King MC, Bawol RD, Hulley SB, Friedman GD. Risk factors for coronary heart disease in adult female twins: genetic heritability and shared environmental influences. Am J Epidemiol. 1987;125:308–318.
    OpenUrlAbstract/FREE Full Text
  45. ↵
    O’Rourke MF, Blazek JV, Morreels CL, Krovetz LJ. Pressure wave transmission along the human aorta. Circ Res. 1968;23:567–579.
    OpenUrlAbstract/FREE Full Text
  46. ↵
    Martin NG, Eaves LJ, Kearsy MJ, Davies P. The power of the classical twin study. Heredity. 1978;40:97–116.
    OpenUrlPubMed
  47. ↵
    Hart DJ, Mootoosamy I, Doyle DV, Spector TD. The relationship between osteoarthritis and osteoporosis in the general population: the Chingford study. Ann Rheum Dis. 1994;53:158–162.
    OpenUrlAbstract/FREE Full Text
  48. ↵
    Christensen K, Vaupel J, Holm NV, Yashin AI. Twin mortality after age six: fetal origin hypothesis versus twin method. BMJ. 1995;310:432–436.
    OpenUrlAbstract/FREE Full Text
  49. ↵
    Laogun AA, Gosling RG. In vivo arterial compliance in man. Clin Phys Physiol Meas. 1982;3:201–212.
    OpenUrlCrossRefPubMed
  50. ↵
    Reynolds CA, Hewitt JK. Issues in the behavioral genetic investigation of gender differences. In: Turner JR, Cardon LR, Hewitt JK, eds. Behavior Genetic Approaches in Behavioral Medicine. New York, NY: Plenum; 1995:189–199.
  51. ↵
    Martin NG, Boomsma DI, Machin G. A twin-pronged attack on complex traits. Nature Genet. 1997;17:387–392.
    OpenUrlCrossRefPubMed
View Abstract
Back to top
Previous ArticleNext Article

This Issue

Hypertension
February 2000, Volume 35, Issue 2
  • Table of Contents
Previous ArticleNext Article

Jump to

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics
  • eLetters

Article Tools

  • Print
  • Citation Tools
    Heritability of Central Systolic Pressure Augmentation
    Harold Snieder, Christopher S. Hayward, Ursula Perks, Raymond P. Kelly, Paul J. Kelly and Tim D. Spector
    Hypertension. 2000;35:574-579, originally published February 1, 2000
    https://doi.org/10.1161/01.HYP.35.2.574

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
  •  Download Powerpoint
  • Article Alerts
    Log in to Email Alerts with your email address.
  • Save to my folders

Share this Article

  • Email

    Thank you for your interest in spreading the word on Hypertension.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Heritability of Central Systolic Pressure Augmentation
    (Your Name) has sent you a message from Hypertension
    (Your Name) thought you would like to see the Hypertension web site.
  • Share on Social Media
    Heritability of Central Systolic Pressure Augmentation
    Harold Snieder, Christopher S. Hayward, Ursula Perks, Raymond P. Kelly, Paul J. Kelly and Tim D. Spector
    Hypertension. 2000;35:574-579, originally published February 1, 2000
    https://doi.org/10.1161/01.HYP.35.2.574
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Related Articles

Cited By...

Subjects

  • Cardiology
    • Etiology
      • Hypertension
        • Hypertension
  • Heart Failure and Cardiac Disease
    • Hypertrophy
  • Genetics
    • Genetics

Hypertension

  • About Hypertension
  • Instructions for Authors
  • AHA CME
  • Guidelines and Statements
  • Permissions
  • Journal Policies
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Editorial Office Address:
7272 Greenville Ave.
Dallas, TX 75231
email: hypertension@heart.org

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2018 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured